Evidence map›Paper›PMID 42881392›Full record

ArticleBMC urology2026

Beyond traditional nephrometry: a 3D quantitative framework for predicting pentafecta and evaluating mediation effects in nephron-sparing surgery.

Jia Li, Zhenting Zhang, Chunsen Yang, Rui Lin, Chao Zhang, Wenfeng Liao, Kun Wang, Sanxiang Li, Xin Yao

Abstract read
PubMed Publisher
In one paragraph

Article in BMC urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jia LiDepartment of Genitourinary Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy Tianjin, Tianjin, China.ORCID http://orcid.org/0009-0009-9728-5316
Zhenting ZhangDepartment of Genitourinary Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy Tianjin, Tianjin, China.
Chunsen YangDepartment of Genitourinary Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy Tianjin, Tianjin, China.
Rui LinDepartment of Genitourinary Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy Tianjin, Tianjin, China.
Chao ZhangDepartment of Genitourinary Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy Tianjin, Tianjin, China.
Wenfeng LiaoDepartment of Genitourinary Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy Tianjin, Tianjin, China.
Kun WangDepartment of Genitourinary Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy Tianjin, Tianjin, China.
Sanxiang LiDepartment of Urology, Inner Mongolia People's Hospital, Inner Mongolia Urological Institute, Hohhot, China.
Xin YaoDepartment of Genitourinary Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy Tianjin, Tianjin, China. yaoxin@tjmuch.com.ORCID http://orcid.org/0000-0002-1544-7273

Funding

The Clinical Trial Fund of the 358 Program of Tianjin Medical University Cancer Institute and Hospital 358-2023-02Tianjin Key Medical Discipline Construction Project TJYXZDXK-3-003A
6 · The paper itself

Abstract

purposeTo establish a three-dimensional (3D) quantitative framework for predicting pentafecta achievement and to explore the underlying compensatory associations in nephron-sparing surgery (NSS).

methodsWe retrospectively analyzed 375 patients undergoing NSS. Preoperative 3D morphometric metrics-specifically contact surface area (CSA) and retained blood-perfused renal volume (RBRV)-were extracted. Pentafecta was strictly defined by optimal perioperative success and 1-year functional preservation (eGFR loss < 10% without chronic kidney disease upstaging). Multivariable logistic regression, quadrant-based phenotypic analysis, and serial mediation modeling were performed to compare predictive performance and explore potential sequential clinical pathways.

resultsPentafecta was achieved in 203 patients (54.1%). The 3D quantitative framework, incorporating CSA, RBRV, and their interaction with baseline eGFR, significantly outperformed traditional nephrometry in discrimination (apparent AUC: 0.752, optimism-corrected AUC: 0.729 vs. 0.697; DeLong test, P = 0.004) and clinical net benefit. Quadrant-based analysis revealed a compensatory "Resilience" phenotype, suggesting that preserving substantial RBRV may effectively buffer the detrimental impact of high surgical complexity. Serial mediation analysis revealed a pattern consistent with statistical sequential mediation: the negative association between anatomical complexity (CSA) and pentafecta achievement was not direct (OR = 0.990, P = 0.683), but rather mediated through a potential sequential pathway involving prolonged warm ischemia time and subsequent postoperative day 1 acute kidney injury (AKI) (indirect effect, P = 0.033).

conclusionThe 3D quantitative framework demonstrates superior predictive performance compared to traditional nephrometry in predicting pentafecta. Maximizing functional volume retention and preemptively mitigating the risk of ischemia-associated AKI appear paramount for individualized surgical planning and optimal long-term recovery.

Indexed as

Imaging, Three-DimensionalKidneyKidney NeoplasmsNephrectomyNephronsOrgan Sparing TreatmentsAgedFemaleHumansMaleMiddle AgedPredictive Value of TestsRetrospective StudiesAcute kidney injuryCarcinoma, renal cellImaging, three-dimensionalMediation analysisNephron-sparing surgery

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.